Tejaswi Biotech Private Limited - Due diligence report

A 360° intelligence report on Tejaswi Biotech Private Limited: trust score, financial health, credit view, compliance, directors, growth and…

2019-01-23 Delhi, Delhi Active Unlisted Active Compliant
Share
TB Tejaswi Biotech Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Tejaswi Biotech Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
63/100
Trust Score
Moderate

Tejaswi Biotech Private Limited is assessed as Moderate with a Trust Score of 63/100. Tejaswi Biotech Private Limited is an active private limited indian non-government company incorporated in 2019, operating in the Business Outsourcing sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Tejaswi Biotech Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
63/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
25/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
35/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
40/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 35/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Elevated gearing (D/E 38%).

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 40/100
NameDIN / PANDesignationAppointedTenureDIN status
UTTAM KUMAR 01234567 Director 01/04/2018 6 yrs Approved
VINAY KUMAR 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • UTTAM KUMAR has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • 3 director exit(s) in the last 3 years.
06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 60
Growth signals & trust indicators
Revenue acceleration: +1.42 over 2 year(s).
Operating for 7 years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence77/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment48/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view52/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 11 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
21 Aug 2024
Director appointed
VINAY KUMAR (Director)
Director ceased
Mona Tamta
Director ceased
Ajit Kumar
23 Feb 2024
Director ceased
NITISH KUMAR
30 Jun 2023
Director ceased
PRABHA SINGH
17 Jun 2022
Director ceased
POONAM SINGH
Director ceased
VINAY KUMAR
23 Jan 2019
Incorporated
Registered with Roc Delhi Ii
Director appointed
UTTAM KUMAR (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 2 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Fantasia Enterprises Private Limited U52100MH1992PTC066494 Mumbai, Maharashtra, India
Tiaana Enterprises Private Limited U51909DL2020PTC372202 New Delhi, Delhi, India
Muse Healthcare Private Limited U85191UP2014PTC065735 Lucknow, Uttar Pradesh, India
Mundhra Fabrics Limited U51101TN1993PLC026117 Tamilnadu, Tamil Nadu, India
Trident Floorings Private Limited U45400MH1998PTC115565 Mumbai, Maharashtra, India
Cross Border Tradex Private Limited U51103DL2008PTC184393 Delhi, Delhi, India
India Thermal Power Private Limited U04010MH1993PTC171444 Mumbai, Maharashtra, India
Amit Prints Pvt Ltd U17119GJ1993PTC019958 Choryasi, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Tejaswi Biotech Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Tejaswi Biotech Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 35/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Tejaswi Biotech Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 63/100, distress signals and MSME payment-delay disclosures - know whether Tejaswi Biotech Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Tejaswi Biotech Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Tejaswi Biotech Private Limited an active company?

Tejaswi Biotech Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Tejaswi Biotech Private Limited financially healthy?

Tejaswi Biotech Private Limited has a Financial Health Score of 25/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Tejaswi Biotech Private Limited?

Its overall Trust Score is 63/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Tejaswi Biotech Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Tejaswi Biotech Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Tejaswi Biotech Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Tejaswi Biotech Private Limited?

Its Credit Risk Score is 35/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.